Cargando…
Personalised therapeutic approaches to glioblastoma: A systematic review
INTRODUCTION: Glioblastoma is the most common and malignant primary brain tumour with median survival of 14.6 months. Personalised medicine aims to improve survival by targeting individualised patient characteristics. However, a major limitation has been application of targeted therapies in a non-pe...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140534/ https://www.ncbi.nlm.nih.gov/pubmed/37122327 http://dx.doi.org/10.3389/fmed.2023.1166104 |